List of Onyvax patents | 6 results

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7303911 Prostate cell lines	Patent 7303911 was granted and assigned to Onyvax on December, 2007 by the United States Patent and Trademark Office.	Onyvax	United States Patent and Trademark Office	7303911	December 4, 2007
‌ US Patent 8097244 Human prostate cell lines in cancer treatment	Patent 8097244 was granted and assigned to Onyvax on January, 2012 by the United States Patent and Trademark Office.	Onyvax	United States Patent and Trademark Office	8097244	January 17, 2012
‌ US Patent 7438922 Human prostate cell lines in cancer treatment	Patent 7438922 was granted and assigned to Onyvax on October, 2008 by the United States Patent and Trademark Office.	Onyvax	United States Patent and Trademark Office	7438922	October 21, 2008
‌ US Patent 8034360 Use of human prostate cell lines in cancer treatment	Patent 8034360 was granted and assigned to Onyvax on October, 2011 by the United States Patent and Trademark Office.	Onyvax	United States Patent and Trademark Office	8034360	October 11, 2011
‌ US Patent 8545835 Human prostate cell lines in cancer treatment		Onyvax	United States Patent and Trademark Office	8545835	October 1, 2013
‌ US Patent 6972128 Use of human prostrate cell lines in prostate cancer treatment	Patent 6972128 was granted and assigned to Onyvax on December, 2005 by the United States Patent and Trademark Office.	Onyvax	United States Patent and Trademark Office	6972128	December 6, 2005